PDF herunterladen
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2019; 06(03): 275-283
DOI: 10.1055/s-0039-3399399
Review Article
Indian Society of Neuroanaesthesiology and Critical Care

Fever in the Neurointensive Care Unit

Siddharth Chavali 
1   Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences (AIIMS), New Delhi, India
,
Manjari Tripathi
2   Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India
,
Vanitha Rajagopalan
1   Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences (AIIMS), New Delhi, India
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 20. August 2019

Accepted after revision: 23. September 2019

Publikationsdatum:
20. November 2019 (online)

   Lizenzen und Reprints

Abstract

Fever occurs commonly in patients admitted to the neurocritical care unit. An increase in the body temperature is known to have deleterious effects on patients with acute nervous system injury and in most cases is associated with an increase in mortality and morbidity of these patients. There are multiple causes of fever in these patients. Due to the potentially devastating effects of fever in patients with cerebral diseases, it warrants treatment in every case. In all patients with acute cerebral damage, treatment of fever and maintenance of euthermia is important to obtain a better functional recovery and to limit any further secondary insult to the brain. This review highlights the etiology and pathophysiology of fever in neurocritical care unit patients, the effects on various organ systems and associated systemic complications, and the evaluation and different therapeutic options available for the management of fever in this patient subset.

Keywords

fever - hyperthermia syndromes - neurointensive care
 

  • References

  • 1 Circiumaru B, Baldock G, Cohen J. A prospective study of fever in the intensive care unit. Intensive Care Med 1999; 25 (07) 668-673
    CrossrefPubMedGoogle Scholar
  • 2 Laupland KB, Shahpori R, Kirkpatrick AW, Ross T, Gregson DB, Stelfox HT. Occurrence and outcome of fever in critically ill adults. Crit Care Med 2008; 36 (05) 1531-1535
    CrossrefPubMedGoogle Scholar
  • 3 Wunderlich CA. Das Verhalten der Eigenwärme in Krankheiten. Leipzig, Germany: O. Wigand; 1870
    Google Scholar
  • 4 Mackowiak PA, Wasserman SS, Levine MM. A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA 1992; 268 (12) 1578-1580
    CrossrefPubMedGoogle Scholar
  • 5 Rincon F, Hunter K, Schorr C, Dellinger RP, Zanotti-Cavazzoni S.. The epidemiology of spontaneous fever and hypothermia on admission of brain injury patients to intensive care units: a multicenter cohort study. J Neurosurg 2014; 121 (04) 950-960
    CrossrefPubMedGoogle Scholar
  • 6 Denborough M. Malignant hyperthermia. Lancet 1998; 352 (9134) 1131-1136
    CrossrefPubMedGoogle Scholar
  • 7 Niven DJ, Gaudet JE, Laupland KB, Mrklas KJ, Roberts DJ, Stelfox HT. Accuracy of peripheral thermometers for estimating temperature: a systematic review and meta-analysis. Ann Intern Med 2015; 163 (10) 768-777
    CrossrefPubMedGoogle Scholar
  • 8 Egi M, Morita K. Fever in non-neurological critically ill patients: a systematic review of observational studies. J Crit Care 2012; 27 (05) 428-433
    CrossrefPubMedGoogle Scholar
  • 9 Boulant JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 2000; 31 (Suppl. 05) S157-S161
    CrossrefPubMedGoogle Scholar
  • 10 Saper CB, Breder CD. The neurologic basis of fever. N Engl J Med 1994; 330 (26) 1880-1886
    CrossrefPubMedGoogle Scholar
  • 11 Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol 2015; 15 (06) 335-349
    CrossrefPubMedGoogle Scholar
  • 12 Ahkee S, Srinath L, Ramirez J. Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis. South Med J 1997; 90 (03) 296-298
    CrossrefPubMedGoogle Scholar
  • 13 Roti Roti JL. Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events. Int J Hyperthermia 2008; 24 (01) 3-15
    CrossrefPubMedGoogle Scholar
  • 14 Bouchama A, al-Sedairy S, Siddiqui S., Shail E, Rezeig M. Elevated pyrogenic cytokines in heatstroke. Chest 1993; 104 (05) 1498-1502
    CrossrefPubMedGoogle Scholar
  • 15 Lambert GP. Role of gastrointestinal permeability in exertional heatstroke. Exerc Sport Sci Rev 2004; 32 (04) 185-190
    PubMedGoogle Scholar
  • 16 Hall DM, Buettner GR, Oberley LW, Xu L, Matthes RD, Gisolfi CV. Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia. Am J Physiol Heart Circ Physiol 2001; 280 (02) H509-H521
    CrossrefPubMedGoogle Scholar
  • 17 Mustafa S, Elgazzar AH, Essam H, Gopinath S, Mathew M. Hyperthermia alters kidney function and renal scintigraphy. Am J Nephrol 2007; 27 (03) 315-321
    CrossrefPubMedGoogle Scholar
  • 18 Atar S, Rozner E, Rosenfeld T. Transient cardiac dysfunction and pulmonary edema in exertional heat stroke. Mil Med 2003; 168 (08) 671-673
    CrossrefPubMedGoogle Scholar
  • 19 Vlad M, Ionescu N, Ispas AT, Giuvărăşteanu I, Ungureanu E, Stoica C. Morphological changes during acute experimental short-term hyperthermia. Rom J Morphol Embryol 2010; 51 (04) 739-744
    PubMedGoogle Scholar
  • 20 Alzeer AH, el-Hazmi MA, Warsy AS, Ansari ZA, Yrkendi MS. Serum enzymes in heat stroke: prognostic implication. Clin Chem 1997; 43 (07) 1182-1187
    CrossrefPubMedGoogle Scholar
  • 21 Dematte JE, O’Mara K, Buescher J. et al. Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med 1998; 129 (03) 173-181
    PubMedGoogle Scholar
  • 22 Etulain J, Lapponi MJ, Patrucchi SJ. et al. Hyperthermia inhibits platelet hemostatic functions and selectively regulates the release of alpha-granule proteins. J Thromb Haemost 2011; 9 (08) 1562-1571
    CrossrefPubMedGoogle Scholar
  • 23 Castillo J, Dávalos A, Noya M. Aggravation of acute ischemic stroke by hyperthermia is related to an excitotoxic mechanism. Cerebrovasc Dis 1999; 9 (01) 22-27
    CrossrefPubMedGoogle Scholar
  • 24 Kiyatkin EA, Sharma HS. Permeability of the blood-brain barrier depends on brain temperature. Neuroscience 2009; 161 (03) 926-939
    CrossrefPubMedGoogle Scholar
  • 25 Nemoto EM, Frankel HM. Cerebral oxygenation and metabolism during progressive hyperthermia. Am J Physiol 1970; 219 (06) 1784-1788
    PubMedGoogle Scholar
  • 26 Yaqub BA. Neurologic manifestations of heatstroke at the Mecca pilgrimage. Neurology 1987; 37 (06) 1004-1006
    CrossrefPubMedGoogle Scholar
  • 27 Bazille C, Megarbane B, Bensimhon D. et al. Brain damage after heat stroke. J Neuropathol Exp Neurol 2005; 64 (11) 970-975
    CrossrefPubMedGoogle Scholar
  • 28 Laxe S, Zúniga-Inestroza L, Bernabeu-Guitart M. [Neurological manifestations and their functional impact in subjects who have suffered heatstroke]. Rev Neurol 2013; 56 (01) 19-24
    PubMedGoogle Scholar
  • 29 Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG. ed. Hospital Epidemiology and Infection Control. Philadelphia: Lippincott Williams and Wilkins; 2004: 1659-1702
    Google Scholar
  • 30 Jain S, Self WH, Wunderink RG. et al. CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015; 373 (05) 415-427
    CrossrefPubMedGoogle Scholar
  • 31 Bagshaw SM, Laupland KB. Epidemiology of intensive care unit-acquired urinary tract infections. Curr Opin Infect Dis 2006; 19 (01) 67-71
    CrossrefPubMedGoogle Scholar
  • 32 Rabinstein AA, Sandhu K. Non-infectious fever in the neurological intensive care unit: incidence, causes and predictors. J Neurol Neurosurg Psychiatry 2007; 78 (11) 1278-1280
    CrossrefPubMedGoogle Scholar
  • 33 Badjatia N, Fernandez L, Schmidt JM. et al. Impact of induced normothermia on outcome after subarachnoid hemorrhage: a case-control study. Neurosurgery 2010; 66 (04) 696-700, discussion 700–701
    CrossrefPubMedGoogle Scholar
  • 34 Andrews PJD, Sleeman DH, Statham PFX. et al. Predicting recovery in patients suffering from traumatic brain injury by using admission variables and physiological data: a comparison between decision tree analysis and logistic regression. J Neurosurg 2002; 97 (02) 326-336
    CrossrefPubMedGoogle Scholar
  • 35 Cooper DJ, Nichol AD, Bailey M. et al. POLAR Trial Investigators and the ANZICS Clinical Trials Group. Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR randomized clinical trial. JAMA 2018; 320 (21) 2211-2220
    CrossrefPubMedGoogle Scholar
  • 36 Krassioukov AV, Karlsson A-K, Wecht JM, Wuermser LA, Mathias CJ, Marino RJ. Joint Committee of American Spinal Injury: Association and International Spinal Cord Society. Assessment of autonomic dysfunction following spinal cord injury: rationale for additions to International Standards for Neurological Assessment. J Rehabil Res Dev 2007; 44 (01) 103-112
    CrossrefPubMedGoogle Scholar
  • 37 Wang Y, Lim LL, Levi C, Heller RF, Fisher J. Influence of admission body temperature on stroke mortality. Stroke 2000; 31 (02) 404-409
    CrossrefPubMedGoogle Scholar
  • 38 den Hertog HM, van der Worp HB, van Gemert HMA. et al. PAIS Investigators. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol 2009; 8 (05) 434-440
    CrossrefPubMedGoogle Scholar
  • 39 Schwarz S, Häfner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000; 54 (02) 354-361
    CrossrefPubMedGoogle Scholar
  • 40 Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv 1998; 49 (09) 1163-1172
    CrossrefPubMedGoogle Scholar
  • 41 Caroff SN, Mann SC. Neuroleptic malignant syndrome. Psychopharmacol Bull 1988; 24 (01) 25-29
    PubMedGoogle Scholar
  • 42 Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J 2013; 13 (04) 533-540
    PubMedGoogle Scholar
  • 43 Dunkley EJC, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96 (09) 635-642
    CrossrefPubMedGoogle Scholar
  • 44 Northoff G. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. J Neural Transm (Vienna) 2002; 109 (12) 1453-1467
    CrossrefPubMedGoogle Scholar
  • 45 Luchini F, Medda P, Mariani MG, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: efficacy and predictors of response. World J Psychiatry 2015; 5 (02) 182-192
    CrossrefPubMedGoogle Scholar
  • 46 Newman EJ, Grosset DG, Kennedy PGE. The parkinsonism-hyperpyrexia syndrome. Neurocrit Care 2009; 10 (01) 136-140
    CrossrefPubMedGoogle Scholar
  • 47 Gaieski DF, Mikkelsen ME, Band RA. et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010; 38 (04) 1045-1053
    CrossrefPubMedGoogle Scholar
  • 48 Póvoa P, Almeida E, Moreira P. et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998; 24 (10) 1052-1056
    CrossrefPubMedGoogle Scholar
  • 49 Zacharski LR, Kyle RA. Significance of extreme elevation of erythrocyte sedimentation rate. JAMA 1967; 202 (04) 264-266
    CrossrefPubMedGoogle Scholar
  • 50 Bouadma L, Luyt CE, Tubach F. et al. PRORATA trial group. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010; 375 (9713) 463-474
    CrossrefPubMedGoogle Scholar
  • 51 Delèvaux I, André M, Colombier M. et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?. Ann Rheum Dis 2003; 62 (04) 337-340
    CrossrefPubMedGoogle Scholar
  • 52 Struck J, Tao C, Morgenthaler NG, Bergmann A. Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 2004; 25 (08) 1369-1372
    CrossrefPubMedGoogle Scholar
  • 53 Al Shuaibi M, Bahu RR, Chaftari AM. et al. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis 2013; 56 (07) 943-950
    CrossrefPubMedGoogle Scholar
  • 54 Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231 (25) 232-235
    CrossrefPubMedGoogle Scholar
  • 55 Dippel DWJ, van Breda EJ, van der Worp HB. et al. PISA-Investigators. Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690]. BMC Cardiovasc Disord 2003; 3: 2
    CrossrefPubMedGoogle Scholar
  • 56 Cormio M, Citerio G. Continuous low dose diclofenac sodium infusion to control fever in neurosurgical critical care. Neurocrit Care 2007; 6 (02) 82-89
    CrossrefPubMedGoogle Scholar
  • 57 Lee BH, Inui D, Suh GY. et al. Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care 2012; 16 (01) R33
    CrossrefPubMedGoogle Scholar
  • 58 Suzuki S, Eastwood GM, Bailey M. et al. Paracetamol therapy and outcome of critically ill patients: a multicenter retrospective observational study. Crit Care 2015; 19: 162
    CrossrefPubMedGoogle Scholar
  • 59 Young P, Saxena M, Bellomo R. et al. HEAT Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Acetaminophen for fever in critically ill patients with suspected infection. N Engl J Med 2015; 373 (23) 2215-2224
    CrossrefPubMedGoogle Scholar
  • 60 Axelrod P. External cooling in the management of fever. Clin Infect Dis 2000; 31 (05) (Suppl. 05) S224-S229
    CrossrefPubMedGoogle Scholar
  • 61 Choi HA, Ko S-B, Presciutti M. et al. Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol. Neurocrit Care 2011; 14 (03) 389-394
    CrossrefPubMedGoogle Scholar
  • 62 Schortgen F, Clabault K, Katsahian S. et al. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med 2012; 185 (10) 1088-1095
    CrossrefPubMedGoogle Scholar
  • 63 Fink EL, Kochanek PM, Clark RSB, Bell MJ. Fever control and application of hypothermia using intravenous cold saline. Pediatr Crit Care Med 2012; 13 (01) 80-84
    CrossrefPubMedGoogle Scholar
  • 64 Gozzoli V, Schöttker P, Suter PM, Ricou B. Is it worth treating fever in intensive care unit patients? Preliminary results from a randomized trial of the effect of external cooling. Arch Intern Med 2001; 161 (01) 121-123
    CrossrefPubMedGoogle Scholar
  • 65 Kumar A, Roberts D, Wood KE. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34 (06) 1589-1596
    CrossrefPubMedGoogle Scholar
  • 66 Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 2005; 40 (Suppl. 04) S240-S245
    CrossrefPubMedGoogle Scholar